An analysis finds a “one size fits all” approach to prescribing opioids after surgery poses risks for addiction in certain patients.

The cannabis-derived substance provides fewer side effects, with less potential for abuse.

Policy shift could improve access to buprenorphine for opioid use disorder, but stigma and training still pose significant challenge.

Study also shows certain patients have an even greater risk of overdose if they fill opioid prescriptions, and strengthens argument against use of opioids for most dental pain.

Minority experience worsening of symptoms over time, especially younger people.

Multiple new surgery studies show progress and opportunity to reduce prescribing and better support pain care across many types of operations.